Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
-
Field
-
be a great opportunity to join the emerging group and further enhance your career with us. We are looking for several excellent, highly motivated postdoc researchers who can join our research group
-
. The TQM Unit carries research in the broad area of condensed matter theory and statistical physics, making use of both numerical and analytic techniques. Postdocs in the Unit have the opportunity
-
) Names and contact information of 2-3 referees, one of which should be a previous employer For more information visit https://www.oist.jp/careers/postdoc-information-theory-probability-and-statistics-unit
-
Mentorship & Collaboration Structure Postdocs will have three WPI-SKCM² mentors. Primary Mentor: A PI from your primary thrust, such as Quantum Matter, Particle & Nuclear Physics & Cosmology, Soft Matter
-
gravitational waves, by pioneering the weak coupling frontier through the use of cutting-edge quantum sensors and devices. QUP operates under a distinctive organizational model in which researchers from a broad
-
education experiences to students and postdoctoral fellows. About the Role Our Supporting Office Staff supports postdocs and graduate students from all over the world, which includes their budget management
-
operates under a distinctive organizational model in which researchers from a broad range of institutions, including KEK, converge at QUP to pursue common scientific objectives. QUP's principal research
-
About the Applicant ⑨ Mentor's Name (Please obtain the mentor’s consent) ⑩ Explanation of Up to Five Key Papers or Achievements (If there are any numerical indicators that demonstrate the excellence
-
modelling across different depths of human evolutionary history, building on methods published in Speidel et al, Nature 2025 and application to new large-scale modern and ancient genetic data. - Developing
-
Tenure-Track Assistant Professor at the Graduate School of Pharmaceutical Studies, Tohoku University
research approaches, including but not limited to those that leverage emerging technologies—such as AI-based analysis, computational science, and iPS cell-based drug discovery models—to identify novel drug